Combination fixed-dose {beta} agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review

Conclusions FABA/ICS as required is clinically effective in adults and adolescents with mild asthma and reduced exacerbations, hospital admissions or unscheduled healthcare visits and exposure to systemic corticosteroids and probably reduces adverse events compared with FABA as required alone. FABA/ICS as required is as effective as regular ICS and reduced asthma-related hospital admissions or unscheduled healthcare visits, and average exposure to ICS, and is unlikely associated with increased adverse events.
Source: Evidence-Based Medicine - Category: Internal Medicine Authors: Tags: Open access, Primary care Evidence synthesis Source Type: research